These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 27387566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K, Yu F, Aldave AJ.
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ, Kamal KM, Vo RC, Yu F.
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [Abstract] [Full Text] [Related]

  • 5. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK, Basak SK, Padilla MD, Yu F, Aldave AJ.
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [Abstract] [Full Text] [Related]

  • 6. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA, Li JY, Mannis MJ.
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C, Yu F, Aldave AJ.
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A, Atallah M, Cherfan G, Awwad ST, Syed ZA, Melki SA.
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.
    Driver TH, Aravena C, Duong HNV, Christenbury JG, Yu F, Basak SK, Aldave AJ.
    Cornea; 2018 Nov; 37(11):1400-1407. PubMed ID: 30157053
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
    Wagoner MD, Welder JD, Goins KM, Greiner MA.
    Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S, Akpek EK, Gehlbach PL, Dunlap K, Ramulu PY.
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM, Jabbour S, Harissi-Dagher M, Tan RRG, Hamel P, Baig K, Ali A.
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.